OTCMKTS:ZYXI - Zynex Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.95 0.00 (0.00 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$4.95
Today's Range$4.94 - $4.99
52-Week Range$2.40 - $5.43
Volume48,156 shs
Average Volume32,956 shs
Market Capitalization$164.84 million
P/E Ratio22.50
Dividend YieldN/A
Beta1.05
Zynex, Inc., a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. The company also distributes private labeled products, such as electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support. In addition, it develops non-invasive blood volume monitors for use in hospitals and surgery centers. The company offers its products for pain management and control; and stroke and spinal cord injury rehabilitation. It sells its products through direct and independent sales representatives primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Receive ZYXI News and Ratings via Email

Sign-up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ZYXI
CUSIPN/A
Phone303-703-4906

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$23.43 million
Cash Flow$0.2764 per share
Book Value$0.15 per share

Profitability

Net Income$7.36 million

Miscellaneous

Employees109
Market Cap$164.84 million
OptionableNot Optionable

Zynex (OTCMKTS:ZYXI) Frequently Asked Questions

What is Zynex's stock symbol?

Zynex trades on the OTCMKTS under the ticker symbol "ZYXI."

How were Zynex's earnings last quarter?

Zynex Inc. (OTCMKTS:ZYXI) issued its earnings results on Tuesday, November, 6th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.07 by $0.01. The firm earned $8.13 million during the quarter, compared to analysts' expectations of $7.96 million. Zynex had a return on equity of 152.81% and a net margin of 33.33%. View Zynex's Earnings History.

What price target have analysts set for ZYXI?

1 brokers have issued 1 year price objectives for Zynex's shares. Their predictions range from $7.00 to $7.00. On average, they anticipate Zynex's share price to reach $7.00 in the next year. This suggests a possible upside of 41.4% from the stock's current price. View Analyst Price Targets for Zynex.

What is the consensus analysts' recommendation for Zynex?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zynex.

Has Zynex been receiving favorable news coverage?

News headlines about ZYXI stock have trended neutral this week, according to InfoTrie Sentiment. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Zynex earned a news impact score of 0.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days.

Who are some of Zynex's key competitors?

Who are Zynex's key executives?

Zynex's management team includes the folowing people:
  • Mr. Thomas Sandgaard, Founder, Pres, CEO & Chairman (Age 60)
  • Mr. Daniel J. Moorhead, Chief Financial Officer (Age 47)
  • Mr. David B. Mogill, VP of Operations
  • Mr. Robert Bird, VP of Marketing
  • Mr. Steve Siefring, Director of Bus. Devel.

How do I buy shares of Zynex?

Shares of ZYXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zynex's stock price today?

One share of ZYXI stock can currently be purchased for approximately $4.95.

How big of a company is Zynex?

Zynex has a market capitalization of $164.84 million and generates $23.43 million in revenue each year. The company earns $7.36 million in net income (profit) each year or $0.22 on an earnings per share basis. Zynex employs 109 workers across the globe.

What is Zynex's official website?

The official website for Zynex is http://www.zynexmed.com.

How can I contact Zynex?

Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The company can be reached via phone at 303-703-4906 or via email at [email protected]


MarketBeat Community Rating for Zynex (OTCMKTS ZYXI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  89 (Vote Outperform)
Underperform Votes:  84 (Vote Underperform)
Total Votes:  173
MarketBeat's community ratings are surveys of what our community members think about Zynex and other stocks. Vote "Outperform" if you believe ZYXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZYXI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel